Abstract
The Impella support devices have received FDA approval for temporary stabilization of patients with cardiogenic shock. The use of these devices in cardiogenic shock secondary to acute myocarditis has not been evaluated in clinical trials. The aim of this study is to report our experience with these
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
